ArticleBMJ open2026

Electronic symptom monitoring of patient-reported outcomes among patients with hepatocellular carcinoma during immunotherapy (PRIME-HCC): protocol for a randomised controlled trial.

Yiqi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.